(RXRX) - Analyzing Recursion Pharmaceuticals's Short Interest
Portfolio Pulse from Benzinga Insights
Recursion Pharmaceuticals (NYSE:RXRX) has seen a decrease in short interest, now at 25.44% of float, down 8.65% from the last report. With 39.76 million shares sold short, it would take about 6.76 days to cover all short positions. This change in short interest could indicate a shift in market sentiment towards RXRX, potentially impacting its stock price in the short term. Compared to its peers, RXRX has a higher short interest, suggesting more bearish sentiment among investors.
May 02, 2024 | 8:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Recursion Pharmaceuticals's short interest has decreased, suggesting a potential shift in market sentiment that could influence its stock price.
A decrease in short interest typically indicates that investors are becoming more bullish on a stock, as fewer traders are betting on its price to fall. This could lead to a positive impact on RXRX's stock price in the short term, especially considering it has a higher short interest compared to its peers, which highlights its significance. However, the market's overall perception and other external factors will also play a crucial role in determining the stock's movement.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100